The estimated Net Worth of Rahul Garella is at least $11.8 Tisíc dollars as of 21 February 2020. Mr. Garella owns over 20,340 units of Endo International plc stock worth over $11,787 and over the last 5 years he sold ENDP stock worth over $0. In addition, he makes $0 as Executive Vice President a International Pharmaceuticals at Endo International plc.
Rahul has made over 1 trades of the Endo International plc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 20,340 units of ENDP stock worth $5,951 on 21 February 2020.
The largest trade he's ever made was exercising 20,340 units of Endo International plc stock on 21 February 2020 worth over $5,951. On average, Rahul trades about 3,390 units every 0 days since 2019. As of 21 February 2020 he still owns at least 40,285 units of Endo International plc stock.
You can see the complete history of Mr. Garella stock trades at the bottom of the page.
Rahul Garella serves as Executive Vice President, International Pharmaceuticals of the Company. In this role, he has responsibility for the overall strategic management, operations and commercial leadership of the International Pharmaceuticals business, which includes Paladin Labs, Canada and Global partnerships in the international markets. Mr. Garella joined Endo in 2014 as Senior Vice President. Mr. Garella has over 23 years’ experience in the pharmaceutical industry across branded and generic pharmaceuticals and APIs with international experience across the European, Asian and Latin America markets. Prior to joining Endo, Mr. Garella served as the Senior Vice President for Glenmark Pharmaceuticals Europe Limited responsible for building and managing their Western European business from 2008 until 2014 and their European and Latin American API business from 2005 until 2008. Previously, he worked with Ranbaxy in their Asia-Pacific division and Orchid Chemicals & Pharmaceuticals. He holds a Master of Business Administration (PGDBM) from the Institute of Management Technology, India as well as a Bachelor degree in Electrical Engineering from the Faculty of Engineering, Jamia Millia, New Delhi, India.
Rahul Garella is 50, he's been the Executive Vice President a International Pharmaceuticals of Endo International plc since 2019. There are 11 older and 5 younger executives at Endo International plc. The oldest executive at Endo International plc is Michael Hyatt, 74, who is the Independent Director.
Rahul's mailing address filed with the SEC is C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN, L2, .
Over the last 11 years, insiders at Endo International plc have traded over $3,455,441 worth of Endo International plc stock and bought 152,347 units worth $3,901,804 . The most active insiders traders include Silva Rajiv De, Paul Campanelli a Shane Cooke. On average, Endo International plc executives and independent directors trade stock every 36 days with the average trade being worth of $12,163. The most recent stock trade was executed by Patrick A Barry on 29 March 2022, trading 59,298 units of ENDP stock currently worth $17,351.
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Endo International plc executives and other stock owners filed with the SEC include: